No clinically significant adverse drug/drug or drug/food interactions have been reported during Foliculin therapy. Concomitant use of Foliculin and Clomifene citrate may potentiate the follicular response, whereas concurrent use of GnRH agonist induced pituitary desensitization may increase the dosage of Foliculin needed to elicit an adequate ovarian response.